Alloy Therapeutics, Inc.
Biotechnology · WALTHAM, MA
BiotechnologySEC Form D
Alloy Therapeutics, Inc. filed a Form D with the U.S. Securities and Exchange Commission on April 15, 2026, reporting $30,020,259 raised toward a $39,999,940 offering.
Incorporated in Delaware and based in WALTHAM, MA, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Alloy Therapeutics, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Jason ColomaDirector
- Errik B. AndersonExecutive Officer · Director
- Logan SnyderDirector
- Ulrik NielsenDirector
- Jason CammDirector
- Alex KolicichDirector
- Piotr BobrowiczExecutive Officer · Director
- Anthony SunDirector
- Alaa HalawaDirector
- Christian KanadyDirector
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised